SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030487
Filing Date
2023-11-07
Accepted
2023-11-07 07:47:07
Documents
91
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clnn20230930_10q.htm   iXBRL 10-Q 2033399
2 EXHIBIT 31.1 ex_565829.htm EX-31.1 12750
3 EXHIBIT 31.2 ex_565830.htm EX-31.2 12515
4 EXHIBIT 32.1 ex_565831.htm EX-32.1 6202
5 EXHIBIT 32.2 ex_565832.htm EX-32.2 6235
11 img.jpg GRAPHIC 83423
  Complete submission text file 0001437749-23-030487.txt   10662426

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clnn-20230930.xsd EX-101.SCH 99171
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20230930_cal.xml EX-101.CAL 68985
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20230930_def.xml EX-101.DEF 598293
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20230930_lab.xml EX-101.LAB 566034
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20230930_pre.xml EX-101.PRE 641840
85 EXTRACTED XBRL INSTANCE DOCUMENT clnn20230930_10q_htm.xml XML 1912572
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 231381619
SIC: 2834 Pharmaceutical Preparations